Fibrinogen Replacement to Prevent Intracranial Haemorrhage in Ischemic Stroke Patients After Thrombolysis (FibER)

Clinical trial NCT05300672 · COMPLETED

Trial details

NCT number: NCT05300672
Sponsor: Azienda Usl di Bologna
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Intracranial Hemorrhages Ischemic Stroke

Start date: 2022-02-08
Primary completion: 2024-12-31
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.